NCT06853145View on ClinicalTrials.gov

Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Hyperpolarized Xe129

Hyperpolarized Xe129-MRI: Patients will undergo hyperpolarized Xe129-MRI at the University of Virginia Radiology Imaging Core (Charlottesville, VA, USA). The entire procedure visit takes approximately 3 hours based on our team's experience.

Trial Locations (1)

22908

RECRUITING

Snyder Building 480 Ray C. Hunt Drive, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT06853145 - Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter